Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1025 of 2051 entries
View as:

Hyzaar Asia HEAALTH (0954A-950)

Phase: N/A Priority: Normal
NCT ID: NCT00354991 Org: User:
Start: 06/01/06 End: 04/01/07 Due: 04/01/08

A Study to Assess the Safety and Efficacy of an Investigational Drug (MK-686) in Patients With Osteoarthritis (0686-006)

Phase: N/A Priority: Normal
NCT ID: NCT00296569 Org: User:
Start: 09/30/05 End: 05/31/06 Due: 05/31/07

Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT00984295 Org: User:
Start: 06/30/00 End: 12/31/01 Due: 12/31/02

Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants (V260-014)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00130832 Org: User:
Start: 10/31/05 End: 07/31/06 Due: 07/31/07

A Dose Finding Study of Preladenant (SCH 420814) for the Treatment of Parkinson's Disease (PD) in Japanese Patients (P06402)

Phase: N/A Priority: Normal
NCT ID: NCT01294800 Org: User:
Start: 02/25/11 End: 06/01/13 Due: 06/01/14

A Study to Compare the Effectiveness of Two Anti-HIV Drug Combinations

Phase: N/A Priority: Normal
NCT ID: NCT00002430 Org: User:
Start: - End: - Due: -

Safety and Efficacy of Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) Versus Lenvatinib as First-line Therapy in Participants With Advanced Hepatocellular Carcinoma (MK-7902-002/E7080-G000-311/LEAP-002)

Phase: N/A Priority: Normal
NCT ID: NCT03713593 Org: User:
Start: 12/31/18 End: 09/24/24 Due: 09/24/25

Neutrophilic Asthma Study With Navarixin (MK-7123, SCH 527123) (MK-7123-017)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00632502 Org: User:
Start: 05/01/08 End: 02/01/09 Due: 02/01/10

Double-blind Ipragliflozin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sitagliptin (MK-0431J-843)

Phase: N/A Priority: Normal
NCT ID: NCT02577003 Org: User:
Start: 11/09/15 End: 11/25/16 Due: 11/25/17

A Single-Dose Study of the Pharmacokinetics of Vibegron (MK-4618) in Adults With Hepatic Insufficiency (MK-4618-013)

Phase: N/A Priority: Normal
NCT ID: NCT01737684 Org: User:
Start: 01/15/13 End: 06/14/13 Due: 06/14/14

Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006)

Phase: N/A Priority: Normal
NCT ID: NCT05298423 Org: User:
Start: 05/03/22 End: 08/19/26 Due: 08/19/27

Dose-Range Finding Study for MK0893 (0893-008)

Phase: N/A Priority: Normal
NCT ID: NCT00479466 Org: User:
Start: 07/31/07 End: 05/31/08 Due: 05/31/09

Study to Assess the Tolerability and Efficacy of Anacetrapib (MK-0859) Co-Administered With Statin in Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-020)

Phase: N/A Priority: Normal
NCT ID: NCT01524289 Org: User:
Start: 02/03/12 End: 11/13/18 Due: 11/13/19

Comparison of Recovery From Rocuronium 1.2 mg/kg Followed by Sugammadex (Org 25969) 16 mg/kg at 3 Minutes With Recovery From Succinylcholine 1.0 mg/kg (19.4.303)(P05946)(MK-8616-026)

Phase: N/A Priority: Normal
NCT ID: NCT00474253 Org: User:
Start: 02/10/06 End: 09/09/06 Due: 09/09/07

Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001)

Phase: N/A Priority: Normal
NCT ID: NCT00520598 Org: User:
Start: 10/31/07 End: 05/31/11 Due: 05/31/12

An Investigational Study of Gardasil™ (qHPV Vaccine) in Reducing the Incidence of Anogenital Warts in Young Men (V501-020)

Phase: N/A Priority: Normal
NCT ID: NCT00090285 Org: User:
Start: 09/03/04 End: 04/03/17 Due: 04/03/18

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-3281 in Healthy and Hepatitis C Infected Male Participants (MK-3281-002)

Phase: N/A Priority: Normal
NCT ID: NCT00635804 Org: User:
Start: 02/19/08 End: 12/22/09 Due: 12/22/10

Comparison of Osteoporosis Disease Management Strategies (0000-039)

Phase: N/A Priority: Normal
NCT ID: NCT00145080 Org: User:
Start: 07/31/04 End: 01/31/06 Due: 01/31/07

Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371)

Phase: N/A Priority: Normal
NCT ID: NCT00381017 Org: User:
Start: 09/30/06 End: - Due: -

Reproducibility and Comparison of Platelet Function Assays With Aspirin and Clopidogrel (MK-0000-167)

Phase: N/A Priority: Normal
NCT ID: NCT01108588 Org: User:
Start: 06/30/10 End: 08/31/10 Due: 08/31/11

Enthesitis With Ultra Sonography Doppler in Spondyloarthropathies Treated With Infliximab (Study P04440)

Phase: N/A Priority: Normal
NCT ID: NCT00686894 Org: User:
Start: 01/31/08 End: 11/30/08 Due: 11/30/09

5 Year Long-term Follow up in Pediatric Participants Who Received PegIntron Plus Rebetol in P02538 Part I (P02538 Pt 2)

Phase: N/A Priority: Normal
NCT ID: NCT00761735 Org: User:
Start: 07/31/07 End: 01/31/13 Due: 01/31/14

V710 Clinical Study in Healthy Male Japanese Subjects (V710-006) (COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00735839 Org: User:
Start: 03/31/08 End: 06/30/08 Due: 06/30/09

Instrument Utility for Suspected Asthma (0000-042)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00211575 Org: User:
Start: 05/31/03 End: 12/31/04 Due: 12/31/05

Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002)

Phase: N/A Priority: Normal
NCT ID: NCT03742895 Org: User:
Start: 12/12/18 End: 06/30/26 Due: 06/30/27